Fabre-Kramer is a pharmaceutical company

Pharmaceutical company

The pharmaceutical industry develops, produces, and markets drugs licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices...

 that specializes in the development of psychotropic drugs

Psychoactive drug

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that crosses the blood–brain barrier and acts primarily upon the central nervous system where it affects brain function, resulting in changes in perception, mood, consciousness, cognition, and behavior...

. Compounds in their current development pipeline include TGFK07AD and TGBA01AD for major depression, TGFK08AA and TGWOOAA for generalized anxiety disorder, and TGFK09SD for hypoactive sexual desire disorder.

The company has also conducted clinical studies on a gepirone

Gepirone

Gepirone is a psychoactive drug and research chemical of the piperazine and azapirone chemical classes. It is currently under clinical development in an extended release form as an anxiolytic and antidepressant agent...

extended release formulation for major depression.